• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良的 Del Nido 心脏停搏液与儿科心脏手术后低主强离子差和高氯血症发生率低有关。

Modified del Nido cardioplegia is associated with low incidence of low main strong ion difference and hyperchloremia in pediatric patients after cardiac surgery.

机构信息

Department of Clinical Engineering Center, Okayama University Hospital, 2-5-1, Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.

Department of Anesthesiology and Resuscitology, Okayama University Hospital, 2-5-1, Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.

出版信息

J Anesth. 2024 Apr;38(2):244-253. doi: 10.1007/s00540-023-03306-0. Epub 2024 Feb 15.

DOI:10.1007/s00540-023-03306-0
PMID:38358399
Abstract

PURPOSE

The aims of this study were (1) to determine the associations of cardioplegic solutions with postoperative main strong ion difference (mSID), which is the difference between sodium ion concentration and chloride ion concentration ([Cl]) and (2) to determine the associations of cardioplegic solutions with markers of organ dysfunction.

METHODS

In this retrospective cohort study, patients aged <5 years who underwent cardiac surgery in a tertiary teaching hospital were included. Patients were classified on the basis of the type of cardioplegic solution: modified del Nido cardioplegia (mDNC) and conventional cardioplegia (CC). The effects of mDNC on postoperative mSID and markers of organ functions were examined using propensity-matched analysis.

RESULTS

A total of 500 cases were included. mDNC solution was used in 163 patients (32.6%). After propensity score matching, patients in the mDNC group (n = 152) had significantly higher minimum mSID [28 (26, 30) mEq/L vs. 27 (25, 29) mEq/L, p = 0.02] and lower maximum [Cl] [112 (109, 114) mEq/L vs. 113 (111, 117) mEq/L, p < 0.001] than patients in the CC group (n = 304). The incidences of low mSID and hyperchloremia in the mDNC group were significantly lower than those in the CC group (63.8 vs. 75.7%, p = 0.01 and 63.2 vs. 79.3%, p < 0.001, respectively). There was no significant difference in the incidence of postoperative acute kidney injury and B-type natriuretic peptide level between the two groups.

CONCLUSION

The use of modified del Nido cardioplegia may reduce the incidence of abnormal mSID and hyperchloremia compared with the use of a chloride-rich cardioplegic solution.

摘要

目的

本研究的目的是:(1)确定心脏停搏液与术后主要强离子差(mSID)的关系,mSID 是钠离子浓度与氯离子浓度[Cl]之差;(2)确定心脏停搏液与器官功能障碍标志物的关系。

方法

本回顾性队列研究纳入了在一家三级教学医院接受心脏手术的<5 岁患者。患者根据心脏停搏液的类型分为改良 Del Nido 心脏停搏液(mDNC)和传统心脏停搏液(CC)。采用倾向评分匹配分析 mDNC 对术后 mSID 和器官功能标志物的影响。

结果

共纳入 500 例患者,其中 163 例(32.6%)使用 mDNC 溶液。在倾向评分匹配后,mDNC 组(n=152)患者的最小 mSID[28(26,30)mEq/L 比 27(25,29)mEq/L,p=0.02]更高,最大[Cl][112(109,114)mEq/L 比 113(111,117)mEq/L,p<0.001]更低。与 CC 组(n=304)相比,mDNC 组的低 mSID 和高氯血症发生率明显更低(63.8%比 75.7%,p=0.01 和 63.2%比 79.3%,p<0.001)。两组患者术后急性肾损伤和 B 型利钠肽水平的发生率无明显差异。

结论

与使用富含氯离子的心脏停搏液相比,使用改良 Del Nido 心脏停搏液可能降低异常 mSID 和高氯血症的发生率。

相似文献

1
Modified del Nido cardioplegia is associated with low incidence of low main strong ion difference and hyperchloremia in pediatric patients after cardiac surgery.改良的 Del Nido 心脏停搏液与儿科心脏手术后低主强离子差和高氯血症发生率低有关。
J Anesth. 2024 Apr;38(2):244-253. doi: 10.1007/s00540-023-03306-0. Epub 2024 Feb 15.
2
The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery.富含氨基酸的 Del Nido 心脏停搏液对冠状动脉旁路移植术患者心肌白细胞积聚和心室功能的影响。
Heart Surg Forum. 2021 Jan 15;24(1):E038-E047. doi: 10.1532/hsf.3265.
3
Del Nido cardioplegia versus blood cardioplegia in adult aortic root surgery.成人心主动脉根部手术中 Del Nido 心脏停搏液与血停搏液的比较。
J Thorac Cardiovasc Surg. 2021 Aug;162(2):514-522.e2. doi: 10.1016/j.jtcvs.2020.01.022. Epub 2020 Jan 30.
4
Modified del Nido versus blood cardioplegia in congenital cardiac surgery.改良 Del Nido 心脏停搏液与血停搏液在先天性心脏手术中的应用比较。
Asian Cardiovasc Thorac Ann. 2022 Jun;30(5):555-560. doi: 10.1177/02184923211048332. Epub 2021 Sep 23.
5
Comparison of del Nido and histidine-tryptophan-ketoglutarate cardioplegic solutions in minimally invasive cardiac surgery.微创心脏手术中 Del Nido 和组氨酸-色氨酸-酮戊二酸心脏停搏液的比较。
J Thorac Cardiovasc Surg. 2022 Oct;164(4):e161-e171. doi: 10.1016/j.jtcvs.2020.11.163. Epub 2020 Dec 13.
6
Effect of Del Nido cardioplegia on ventricular arrhythmias after cardiovascular surgery.Del Nido 心脏停搏液对心血管手术后室性心律失常的影响。
BMC Cardiovasc Disord. 2021 Jan 13;21(1):32. doi: 10.1186/s12872-020-01844-z.
7
Clinical impact of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial.成人心血管手术中 Del Nido 心脏停搏液的临床影响:一项前瞻性随机试验。
J Thorac Cardiovasc Surg. 2023 Nov;166(5):1458-1467. doi: 10.1016/j.jtcvs.2022.01.044. Epub 2022 Feb 8.
8
Re-dosing of del Nido cardioplegia in adult cardiac surgery requiring prolonged aortic cross-clamp.成人心血管手术中需要长时间阻断主动脉时重新给予 Del Nido 心脏停搏液。
Interact Cardiovasc Thorac Surg. 2022 Mar 31;34(4):556-563. doi: 10.1093/icvts/ivab310.
9
Initial experience with del Nido cardioplegia solution at a Pediatric and Congenital Cardiac Surgery Program in Brazil.巴西儿科和先天性心脏病外科项目中使用 Del Nido 心脏停搏液的初步经验。
Perfusion. 2022 Oct;37(7):684-691. doi: 10.1177/02676591211020471. Epub 2021 Jun 3.
10
Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution.成人心脏手术中使用德尔尼多心脏停搏液的短期结果。
Perfusion. 2016 Jan;31(1):27-33. doi: 10.1177/0267659115599453. Epub 2015 Jul 30.

引用本文的文献

1
Single-dose modified bloodless del Nido cardioplegia for minimally invasive cardiac surgery.单剂量改良无血del Nido心脏停搏液用于微创心脏手术
Front Cardiovasc Med. 2025 Feb 25;12:1448310. doi: 10.3389/fcvm.2025.1448310. eCollection 2025.

本文引用的文献

1
Myocardial Protection in Adult Cardiac Surgery With del Nido Versus Blood Cardioplegia: A Systematic Review and Meta-Analysis.成人心血管手术中 Del Nido 液与血停搏液的心肌保护作用:系统评价和荟萃分析。
Heart Lung Circ. 2021 May;30(5):642-655. doi: 10.1016/j.hlc.2020.10.016. Epub 2020 Dec 17.
2
Association of Chloride Ion and Sodium-Chloride Difference With Acute Kidney Injury and Mortality in Critically Ill Patients.危重症患者中氯离子及氯化钠差值与急性肾损伤和死亡率的关联
Crit Care Explor. 2020 Nov 24;2(12):e0247. doi: 10.1097/CCE.0000000000000247. eCollection 2020 Dec.
3
Modified Del Nido Cardioplegia and Its Evaluation in a Piglet Model.
改良的 Del Nido 心脏停搏液及其在小型猪模型中的评估。
Semin Thorac Cardiovasc Surg. 2021;33(1):84-92. doi: 10.1053/j.semtcvs.2020.03.002. Epub 2020 May 7.
4
Lactated Ringer's as a Base Solution for del Nido Cardioplegia.乳酸林格氏液作为del Nido心脏停搏液的基础溶液。
J Extra Corpor Technol. 2019 Sep;51(3):153-159.
5
Hyperchloremia and acute kidney injury: a retrospective observational cohort study on a general mixed medical-surgical not ICU-hospitalized population.高氯血症与急性肾损伤:一项针对普通混合内科-外科非 ICU 住院人群的回顾性观察性队列研究。
Intern Emerg Med. 2020 Mar;15(2):273-280. doi: 10.1007/s11739-019-02165-6. Epub 2019 Aug 6.
6
Hyperchloremia Is Not an Independent Risk Factor for Postoperative Acute Kidney Injury in Pediatric Cardiac Patients.高氯血症不是儿科心脏患者术后急性肾损伤的独立危险因素。
J Cardiothorac Vasc Anesth. 2019 Jul;33(7):1939-1945. doi: 10.1053/j.jvca.2018.12.009. Epub 2018 Dec 5.
7
Traditional approach versus Stewart approach for acid-base disorders: Inconsistent evidence.传统方法与斯图尔特方法治疗酸碱紊乱:证据不一致。
SAGE Open Med. 2018 Sep 25;6:2050312118801255. doi: 10.1177/2050312118801255. eCollection 2018.
8
Balanced Crystalloids versus Saline in Noncritically Ill Adults.非危重症成年患者使用平衡晶体液与生理盐水的比较。
N Engl J Med. 2018 Mar 1;378(9):819-828. doi: 10.1056/NEJMoa1711586. Epub 2018 Feb 27.
9
Sodium-Chloride Difference as a Simple Parameter for Acid-Base Status Assessment.氯化钠差值作为评估酸碱状态的简单参数
Am J Kidney Dis. 2017 May;69(5):707-708. doi: 10.1053/j.ajkd.2016.12.019. Epub 2017 Mar 9.
10
Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients.高氯血症以及血清氯化物适度升高与严重脓毒症和脓毒性休克患者的急性肾损伤相关。
Crit Care. 2016 Oct 6;20(1):315. doi: 10.1186/s13054-016-1499-7.